Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
mTOR inhibitor-8
Cat. No.:
OB0225LY-0482
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
mTOR inhibitor-8 is a selective mTOR inhibitor that regulates cell growth and metabolism.
Synonym:
mTOR-IN-8; 2489196-70-3; mTOR inhibitor-8; 2-[5-(4-Chlorophenyl)-3-(4-methoxyphenyl)-3,4-dihydropyrazol-2-yl]-4-pyridin-4-yl-1,3-thiazole
CAS No.:
2489196-70-3
Compound CID:
154573769
Formula:
C24H19ClN4OS
Formula Weight:
446.95
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
mTOR inhibitor-8 can be used to study the mechanisms of cell proliferation and death or play an important role in cancer biology research.
Library Information
Targets:
PI3K/Akt/mTOR pathway
Receptors:
mTOR
Pathways:
PI3K/Akt/mTOR signaling; Autophagy
Plate Number:
AOCL-7
Plate Location:
b11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
20 mg/mL; 44.75 mM
